Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03757910Early Phase 1Terminated
Brain Imaging in the Diabetes Prevention Program Outcomes Study
Alzheimer Disease
PrincipalinvestigatorStart date: 2019-10-01
NCT03389100Phase 2Enrolling By Invitation
Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
Diabetes Mellitus, Type 2Pre-diabetes
PrincipalinvestigatorStart date: 2018-07-24
NCT02470260Active Not Recruiting
Northern Manhattan Study of Metabolism and Mind
Cognition - OtherDepressive SymptomsDiabetes+2 more
PrincipalinvestigatorStart date: 2012-01-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

Metabolic SyndromeDiabetes Mellitus, Type 2Diabetes+1 more

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score17%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Alzheimer DiseaseDiabetesDiabetes Mellitus, Type 2
Similarity Score13%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

Metabolic SyndromeDiabetes Mellitus, Type 2Prediabetic State
Similarity Score13%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

Prediabetic StateDiabetes Mellitus, Type 2Metabolic Syndrome
Similarity Score13%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Metabolic SyndromePrediabetic State
Similarity Score9%

David s Ludwig, MD, PhD

Boston Children's Hospital

Related
17 trials

Shared therapeutic areas:

DiabetesMetabolic Syndrome

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score9%

Timothy Bailey, MD

AMCR Institute

Related
19 trials

Shared therapeutic areas:

DiabetesDiabetes Mellitus, Type 2

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score9%

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes
Similarity Score9%

Paolo Bonato, PhD

Spaulding Rehabilitation Hospital

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score4%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Depressive Symptoms
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03757910Early Phase 1PrincipalInvestigator

Brain Imaging in the Diabetes Prevention Program Outcomes Study

Alzheimer Disease
Terminated
NCT03389100Phase 2PrincipalInvestigator

Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.

Diabetes Mellitus, Type 2Pre-diabetes
Enrolling By Invitation
NCT02470260PrincipalInvestigator

Northern Manhattan Study of Metabolism and Mind

Cognition - OtherDepressive SymptomsDiabetes+2 more
Active Not Recruiting

All 3 trials loaded